Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials!!

Clinical Trial 15689

East Providence, RI 02914


Study Summary:

Multicenter, randomized, double-blind, placebo-controlled, parallel-group two year study to evaluate the effect of Subcutaneous ro4909832 on cognition and function in Prodromal Alzheimer's disease.


Qualified Participants Must:

• Be between 50 and 85 years of age
• Have a study partner to provide information as to the subjects cognitive and functional abilities
• Not be currently taking medication for the treatment of AD MMSE of 24 or above


Qualified Participants May Receive:

Subcutaneous injection of Study Medication every 4 weeks for 2 years. Compensation for time and travel Study related assessments


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.